Lucid Group
@mededlucid
We are a multi-capability healthcare communications company. We bring magic to our clients and programmes. We transform lives. Always.
ID: 443678145
http://www.wearelucidgroup.com 22-12-2011 12:28:22
3,3K Tweet
927 Followers
749 Following
The team enjoying the PM Society Awards today. #healthcarecommunications #innovation #creativity #LucidLife
Watch “Extraordinary lives: advancing change in rare diseases (Part 1)” on #Vimeo vimeo.com/687902087 #transforminglives Rare Disease Day
Extraordinary lives: advancing change in rare diseases (Part 1) pmlive.com/pmhub/medical_… via Pharmaceutical Market Europe
Watch “Extraordinary lives: advancing change in rare diseases (Part 1)” on #Vimeo vimeo.com/687902087 We're extending the conversation for Rare Disease Day. #TransformingLives
My Journey into MedComms #LucidLife pmlive.com/pmhub/medical_… via Pharmaceutical Market Europe
#IWD2022 may have passed but the conversation shouldn't. Read Jade's story here: How I’m helping to #BreakTheBias pmlive.com/pmhub/medical_… via Pharmaceutical Market Europe
Extraordinary lives: advancing change in rare diseases Part 1 now available pmlive.com/pmhub/medical_… via Pharmaceutical Market Europe Please join in the conversation. What more can be done to help advance change in rare diseases. Rare Disease Day Rare Disease UK
Why is raising awareness of rare diseases so important? Because 300m people are living with a rare disease and we still have a lot to do as discussed by the panel in Extraordinary lives: advancing change in rare diseases (Part 1) pmlive.com/pmhub/medical_… via Pharmaceutical Market Europe
Why is raising awareness of rare diseases so important? Because 300m people are living with a rare disease and we still have a lot to do as discussed by the panel in Extraordinary lives: advancing change in rare diseases (Part 1) pmlive.com/pmhub/medical_… via Pharmaceutical Market Europe
In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases (Part 2) pmlive.com/pmhub/medical_… via Pharmaceutical Market Europe